000 01671 a2200457 4500
005 20250515184756.0
264 0 _c20091203
008 200912s 0 0 eng d
022 _a1538-7445
024 7 _a10.1158/0008-5472.CAN-08-3289
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCurran, Michael A
245 0 0 _aTumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors.
_h[electronic resource]
260 _bCancer research
_cOct 2009
300 _a7747-55 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenocarcinoma
_ximmunology
650 0 4 _aAdjuvants, Immunologic
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aAntigens, CD
_ximmunology
650 0 4 _aCD4-Positive T-Lymphocytes
_ximmunology
650 0 4 _aCD8-Positive T-Lymphocytes
_ximmunology
650 0 4 _aCTLA-4 Antigen
650 0 4 _aCancer Vaccines
_ximmunology
650 0 4 _aCarboxypeptidases A
_xpharmacology
650 0 4 _aCricetinae
650 0 4 _aDendritic Cells
_ximmunology
650 0 4 _aDrug Synergism
650 0 4 _aGranulocyte-Macrophage Colony-Stimulating Factor
_xpharmacology
650 0 4 _aKiller Cells, Natural
_ximmunology
650 0 4 _aMale
650 0 4 _aMelanoma, Experimental
_ximmunology
650 0 4 _aMembrane Proteins
_ximmunology
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aProstatic Neoplasms
_ximmunology
650 0 4 _aT-Lymphocytes, Regulatory
_ximmunology
700 1 _aAllison, James P
773 0 _tCancer research
_gvol. 69
_gno. 19
_gp. 7747-55
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-08-3289
_zAvailable from publisher's website
999 _c19137920
_d19137920